Sale!

KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the KCNE1 gene, which are associated with Jervell and Lange-Nielsen Syndrome Type 2 (JLNS2). JLNS2 is a rare inherited condition characterized by profound bilateral sensorineural hearing loss and long QT syndrome, which can lead to arrhythmias and sudden cardiac death. The test is crucial for individuals with a family history of JLNS2 or those exhibiting symptoms related to the condition, as it can confirm the diagnosis and help in managing the syndrome effectively. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect the genetic variations linked to this syndrome. Through early detection provided by the KCNE1 Gene Test, affected individuals can receive timely intervention and counseling, significantly improving their quality of life and reducing the risk of life-threatening cardiac events.

Description

KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 Genetic Test

Test Name: KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 Genetic Test

Components: KCNE1 gene sequencing using NGS technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNE1 Gene Jervell and Lange-Nielsen Syndrome Type 2 NGS Genetic DNA Test gene KCNE1

Test Details: The KCNE1 gene is a gene that provides instructions for making a protein called potassium voltage-gated channel subfamily E regulatory subunit 1. This protein plays a role in regulating the flow of potassium ions across cell membranes, which is important for the normal function of the heart. Jervell and Lange-Nielsen Syndrome Type 2 (JLNS2) is a rare genetic disorder characterized by a combination of deafness and a heart condition called long QT syndrome (LQTS). LQTS is a disorder of the heart’s electrical system that can lead to irregular heartbeats and fainting spells. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the KCNE1 gene, to identify genetic mutations or variations that may be associated with a particular condition or disease. Therefore, a KCNE1 gene Jervell and Lange-Nielsen Syndrome Type 2 NGS genetic test would involve sequencing the KCNE1 gene using next-generation sequencing technology to identify any genetic mutations or variations that may be associated with Jervell and Lange-Nielsen Syndrome Type 2. This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment decisions for individuals suspected to have this syndrome.

Test Name	KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNE1 Gene Jervell and Lange-Nielsen syndrome type 2 NGS Genetic DNA Test gene KCNE1
Test Details	The KCNE1 gene is a gene that provides instructions for making a protein called potassium voltage-gated channel subfamily E regulatory subunit 1. This protein plays a role in regulating the flow of potassium ions across cell membranes, which is important for the normal function of the heart. Jervell and Lange-Nielsen syndrome type 2 (JLNS2) is a rare genetic disorder characterized by a combination of deafness and a heart condition called long QT syndrome (LQTS). LQTS is a disorder of the heart’s electrical system that can lead to irregular heartbeats and fainting spells. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous analysis of multiple genes, including the KCNE1 gene, to identify genetic mutations or variations that may be associated with a particular condition or disease. Therefore, a KCNE1 gene Jervell and Lange-Nielsen syndrome type 2 NGS genetic test would involve sequencing the KCNE1 gene using next-generation sequencing technology to identify any genetic mutations or variations that may be associated with Jervell and Lange-Nielsen syndrome type 2. This test can help in confirming a diagnosis, predicting disease progression, and guiding treatment decisions for individuals suspected to have this syndrome.